𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Indinavir/ritonavir 800/100 mg bid and efavirenz 600 mg qd in patients failing treatment with combination nucleoside reverse transcriptase inhibitors: 96-week outcomes of HIV-NAT 009

✍ Scribed by MA Boyd; U Siangphoe; K Ruxrungtham; CJ Duncombe; M Stek; JMA Lange; DA Cooper; P Phanuphak


Book ID
111063253
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
132 KB
Volume
6
Category
Article
ISSN
1464-2662

No coin nor oath required. For personal study only.